Elisa B Gordon Perez Mena, MD | |
101 Divine Dr Ste 1, Davenport, FL 33897-9571 | |
(863) 256-3225 | |
(844) 388-6186 |
Full Name | Elisa B Gordon Perez Mena |
---|---|
Gender | Female |
Speciality | General Practice |
Experience | 32 Years |
Location | 101 Divine Dr Ste 1, Davenport, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720680887 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | ACN1296 (Florida) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida Medical Associates Llc | 0648271155 | 122 |
News Archive
The common belief that tumors arise via activation of a few genes that "drive" cancer development is unsupported by a widespread investigation into those genes and others in three large patient genetic databases, according to a study led by Yale Cancer Center researchers.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
Like childhood cancers, early life epilepsies represent many rare disorders with diverse underlying causes. Unlike childhood cancers, little has changed in the outcomes of early life epilepsies in the past few decades, despite advances in diagnostic technologies and availability of new treatments.
The Foundation for Physical Therapy has awarded Brown University a $2.5-million, five-year grant for a new center of excellence to spur research in the field. In the Center on Health Services Training and Research, Brown, Boston University, and the University of Pittsburgh will train researchers and seed new studies to build the evidence base for physical therapy care and to improve how care is delivered.
Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine, JAMA.
› Verified 2 days ago
Entity Name | Florida Medical Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336153709 PECOS PAC ID: 0648271155 Enrollment ID: O20070126000169 |
News Archive
The common belief that tumors arise via activation of a few genes that "drive" cancer development is unsupported by a widespread investigation into those genes and others in three large patient genetic databases, according to a study led by Yale Cancer Center researchers.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
Like childhood cancers, early life epilepsies represent many rare disorders with diverse underlying causes. Unlike childhood cancers, little has changed in the outcomes of early life epilepsies in the past few decades, despite advances in diagnostic technologies and availability of new treatments.
The Foundation for Physical Therapy has awarded Brown University a $2.5-million, five-year grant for a new center of excellence to spur research in the field. In the Center on Health Services Training and Research, Brown, Boston University, and the University of Pittsburgh will train researchers and seed new studies to build the evidence base for physical therapy care and to improve how care is delivered.
Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine, JAMA.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Elisa B Gordon Perez Mena, MD 601 S Harbour Island Blvd Ste 200, Tampa, FL 33602-5925 Ph: (800) 480-5243 | Elisa B Gordon Perez Mena, MD 101 Divine Dr Ste 1, Davenport, FL 33897-9571 Ph: (863) 256-3225 |
News Archive
The common belief that tumors arise via activation of a few genes that "drive" cancer development is unsupported by a widespread investigation into those genes and others in three large patient genetic databases, according to a study led by Yale Cancer Center researchers.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
Like childhood cancers, early life epilepsies represent many rare disorders with diverse underlying causes. Unlike childhood cancers, little has changed in the outcomes of early life epilepsies in the past few decades, despite advances in diagnostic technologies and availability of new treatments.
The Foundation for Physical Therapy has awarded Brown University a $2.5-million, five-year grant for a new center of excellence to spur research in the field. In the Center on Health Services Training and Research, Brown, Boston University, and the University of Pittsburgh will train researchers and seed new studies to build the evidence base for physical therapy care and to improve how care is delivered.
Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine, JAMA.
› Verified 2 days ago
Dr. Tamara Ivelisse Guzman Rodriguez, MD General Practice Medicare: Medicare Enrolled Practice Location: 130 Ridge Center Dr, Davenport, FL 33837 Phone: 866-234-8534 | |
Teodoro Medina, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 111 Webb Dr, Davenport, FL 33837 Phone: 863-421-9447 Fax: 863-421-1806 | |
Dr. Ricardo R Sanchez Maceira, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 111 Webb Dr, Davenport, FL 33837 Phone: 863-421-9447 Fax: 863-421-1806 | |
Dr. Reyna Isabel Lajara, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 127 Ridge Center Dr, Davenport, FL 33837 Phone: 863-421-7400 Fax: 863-421-7448 | |
Ladapo Shyngle, M.D., MPH General Practice Medicare: Not Enrolled in Medicare Practice Location: 121 Webb Dr, Suite 100, Davenport, FL 33837 Phone: 863-422-0001 Fax: 863-422-0003 | |
Yamil Carlo Lopez, General Practice Medicare: Medicare Enrolled Practice Location: 2330 North Blvd W, Davenport, FL 33837 Phone: 407-931-0444 Fax: 407-962-4446 |